{"id":"https://openalex.org/W2249145015","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.3560","title":"Phase I study of BAY 73\u20134506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced refractory colorectal carcinoma (CRC)","display_name":"Phase I study of BAY 73\u20134506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced refractory colorectal carcinoma (CRC)","publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W2249145015","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.3560","mag":"2249145015"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.27.15_suppl.3560","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.3560","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.3560","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018436714","display_name":"Dirk Strumberg","orcid":"https://orcid.org/0000-0001-7053-8365","observed_orcids":["https://orcid.org/0000-0001-7053-8365"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D. Strumberg","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107233200","display_name":"Max Ernst Scheulen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. E. Scheulen","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067135726","display_name":"Annette Frost","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Frost","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109229953","display_name":"Martin B\u00fcchert","orcid":"https://orcid.org/0000-0001-5844-8711","observed_orcids":["https://orcid.org/0000-0001-5844-8711"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. B\u00fcchert","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111696351","display_name":"O. Christensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"O. Christensen","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Wagner","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059259953","display_name":"Roland Heinig","orcid":"https://orcid.org/0000-0002-4645-5428","observed_orcids":["https://orcid.org/0000-0002-4645-5428"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R. Heinig","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021363817","display_name":"Ulrike Fasol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U. Fasol","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112408355","display_name":"Klaus B. Mross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K. Mross","raw_affiliation_strings":["Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marienhospital Herne, University of Bochum, Herne, Germany; West German Cancer Center, Essen, Germany; Tumor Biology Center, Freiburg, Germany; University Hospital, Freiburg, Germany; Bayer HealthCare Pharmaceuticals, Montville, NJ; Bayer Scherling Pharma, Berlin and Wuppertal, Germany","institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I4210088550"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"15_suppl","first_page":"3560","last_page":"3560"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.5920000076293945},{"id":"https://openalex.org/keywords/vegfr-inhibition","display_name":"VEGFR inhibition","score":0.7099999785423279},{"id":"https://openalex.org/keywords/kit","display_name":"KIT","score":0.550000011920929},{"id":"https://openalex.org/keywords/ret","display_name":"RET","score":0.9319999814033508},{"id":"https://openalex.org/keywords/fibroblast-growth-factor-receptor","display_name":"fibroblast growth factor receptor","score":0.8980000019073486},{"id":"https://openalex.org/keywords/pdgfr","display_name":"PDGFR","score":0.9779999852180481},{"id":"https://openalex.org/keywords/raf","display_name":"Raf","score":0.7369999885559082},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.781000018119812},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9589999914169312},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.6629999876022339},{"id":"https://openalex.org/keywords/soluble-vegfr-2","display_name":"soluble VEGFR-2","score":0.9639999866485596},{"id":"https://openalex.org/keywords/dce-mri","display_name":"DCE-MRI","score":0.8539999723434448},{"id":"https://openalex.org/keywords/hand-foot-skin-reaction","display_name":"hand-foot skin reaction","score":0.9089999794960022},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.4410000145435333},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6793445348739624},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5813857316970825},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5731778144836426},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.48960214853286743},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4738614559173584},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.4684448540210724},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4373200535774231},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4164809584617615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4122604727745056},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4103041887283325},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32935065031051636},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2525649070739746},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18467387557029724},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17257636785507202},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15641847252845764},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2009.27.15_suppl.3560","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.3560","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.3560","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2266538675","https://openalex.org/W2241910342","https://openalex.org/W3011679583","https://openalex.org/W2018348203","https://openalex.org/W2278365937","https://openalex.org/W2099259685","https://openalex.org/W2250025515","https://openalex.org/W2595387994","https://openalex.org/W2264269079","https://openalex.org/W2243664949"],"abstract_inverted_index":{"3560^":[0],"Background:":[1],"BAY":[2,28,52,115,221,300,309],"73\u20134506":[3,29,116,222,301,310],"is":[4,357,555,566,583],"a":[5,32,224,236,246,317,340,512,556,561,570,633],"potent":[6],"inhibitor":[7],"of":[8,35,51,59,79,90,119,156,162,209,241,262,294,320,345,352,364,379,409,418,426,465,502,569,598,603,649],"the":[9,44,260,372,376,389,423,429,478,499,529,534,542,551,567,578,601,611,638,646,653],"receptor":[10],"tyrosine":[11],"kinases":[12,21],"(VEGFR,":[13],"KIT,":[14],"RET,":[15],"FGFR":[16],"and":[17,19,23,46,77,87,135,192,218,265,284,292,367,388,404,411,414,416,432,453,590,619,652],"PDGFR)":[18],"serine/threonine":[20],"(RAF":[22],"p38MAPK).":[24],"In":[25,369],"in-vivo":[26],"models,":[27],"has":[30,591],"demonstrated":[31,298],"broad":[33],"spectrum":[34],"antitumor":[36,279],"activity.":[37],"Methods:":[38],"This":[39],"phase":[40],"I":[41],"study":[42],"investigated":[43],"safety":[45],"pharmacokinetic":[47],"(PK)/pharmacodynamic":[48],"(PD)":[49],"profiles":[50],"73\u20134506,":[53],"given":[54],"orally":[55],"in":[56,65,160,227,288,328,347,528,560,577,585,600,625,637],"repeating":[57],"cycles":[58],"21":[60,78,321],"days":[61,63,75,148,322,324],"on/7":[62,323],"off,":[64],"patients":[66,107,163,244,329],"with":[67,108,114,330,339,371,594,627,632],"refractory":[68,332],"CRC.":[69,333],"PK":[70],"assessments":[71],"were":[72,94,112,164,211],"performed":[73],"on":[74,304,487,498],"1":[76],"cycle":[80],"1.":[81],"PD":[82],"markers":[83],"-":[84,93],"including":[85,281],"DCE-MRI":[86,297],"plasma":[88],"levels":[89,291],"VEGF/soluble":[91],"VEGFR-2":[92,290],"assessed":[95],"at":[96,117,233,255,312],"each":[97],"cycle.":[98],"Tumor":[99],"response":[100,248],"was":[101,146,238,302,326,337],"evaluated":[102,576],"per":[103],"RECIST.":[104],"Results:":[105],"38":[106],"actively":[109],"progressing":[110],"CRC":[111],"treated":[113],"doses":[118],"60":[120],"mg":[121,126,131,137,314],"(n":[122,127,132,138],"=":[123,128,133,139],"1),":[124],"120":[125],"4),":[129],"160":[130,231,313],"26),":[134],"220":[136],"7)":[140],"once":[141],"daily.":[142],"Median":[143],"treatment":[144,263,318,574],"duration":[145],"56.5":[147],"(range,":[149],"7\u2013219":[150],"days).":[151],"Drug-related":[152],"adverse":[153],"events":[154],"(AEs)":[155],"all":[157,472],"grades":[158],"reported":[159],">20%":[161],"hand-foot":[165],"skin":[166],"reaction":[167],"(HFSR)":[168],"(61%;":[169],"CTC":[170,175,180,187,195],"3\u20134,":[171],"32%),":[172],"fatigue":[173,214],"(45%;":[174],"3,":[176,181,188,196],"11%),":[177],"hoarseness":[178],"(24%;":[179,186],"3%),":[182,189],"mucositis":[183],"(24%),":[184,191],"diarrhea":[185],"anorexia":[190],"hypertension":[193,219],"(21%;":[194],"13%).":[197],"Treatment-related":[198],"AEs":[199],"leading":[200],"to":[201,230,399,422,471,477],"dose":[202],"reduction,":[203],"interruption,":[204],"or":[205,439,443,488,520,573,581],"discontinuation":[206],"(in":[207],"\u22652":[208],"patients)":[210],"HFSR":[212],"(26%),":[213],"(18%),":[215],"thrombopenia":[216],"(8%),":[217],"(5%).":[220],"showed":[223],"dose-dependent":[225],"increase":[226],"exposure":[228],"up":[229],"mg,":[232],"which":[234,616],"point":[235],"plateau":[237],"reached.":[239],"One":[240],"27":[242],"evaluable":[243,348],"achieved":[245],"partial":[247],"(4%),":[249],"15":[250],"had":[251,267,276],"stable":[252],"disease":[253,341],"(SD)":[254],"least":[256],"7":[257],"weeks":[258,273],"after":[259,489],"start":[261],"(55%),":[264],"6":[266],"SD":[268],"for":[269,392,526,615],"more":[270,643],"than":[271],"23":[272],"(22%).":[274],"Patients":[275],"extensive":[277],"previous":[278],"treatment,":[280],"bevacizumab":[282],"(44%)":[283],"cetuximab":[285],"(59%).":[286],"Decreases":[287],"soluble":[289],"iAUC60s":[293],"Gd-DTPA":[295],"by":[296,375],"that":[299,484,544,550],"active":[303],"biologically":[305],"relevant":[306],"markers.":[307],"Conclusions:":[308],"dosing":[311],"daily,":[315],"using":[316],"schedule":[319],"off":[325],"feasible":[327],"advanced":[331],"Promising":[334],"clinical":[335,482,579,587,604],"activity":[336],"shown,":[338],"control":[342],"rate":[343],"(PR+SD)":[344],"59%":[346],"patients.":[349],"Mutational":[350],"analysis":[351],"selected":[353],"genes":[354],"(KRAS,":[355],"BRAF)":[356],"ongoing.":[358],"[Table:":[359],"see":[360],"text]":[361],"ASCO":[362,377,397,424,463,535,647],"Conflict":[363,378,425,464,648],"Interest":[365,380,427,466,650],"Policy":[366,381,467,494,612,629,651],"Exceptions":[368],"compliance":[370],"guidelines":[373],"established":[374],"(J":[382,456,505],"Clin":[383,457,506],"Oncol.":[384,458,507],"2006":[385,459,508],"Jan":[386,460,509],"20;24[3]:519\u2013521)":[387],"Accreditation":[390],"Council":[391],"Continuing":[393],"Medical":[394],"Education":[395],"(ACCME),":[396],"strives":[398],"promote":[400],"balance,":[401],"independence,":[402],"objectivity,":[403],"scientific":[405],"rigor":[406],"through":[407],"disclosure":[408,468],"financial":[410,431,500],"other":[412,433,454],"interests,":[413],"identification":[415],"management":[417],"potential":[419],"conflicts.":[420],"According":[421],"Policy,":[428],"following":[430],"relationships":[434,501],"must":[435],"be":[436,524],"disclosed:":[437],"employment":[438],"leadership":[440],"position,":[441],"consultant":[442],"advisory":[444],"role,":[445],"stock":[446],"ownership,":[447],"honoraria,":[448],"research":[449,589],"funding,":[450],"expert":[451,559],"testimony,":[452],"remuneration":[455],"20;24[3]:520).":[461],"The":[462],"requirements":[469],"apply":[470],"authors":[473,617],"who":[474],"submit":[475],"abstracts":[476],"Annual":[479,531,639],"Meeting.":[480],"For":[481,642],"trials":[483,607],"began":[485],"accrual":[486],"April":[490],"29,":[491],"2004,":[492],"ASCO's":[493,628],"places":[495],"some":[496],"restrictions":[497],"principal":[503,513,552],"investigators":[504],"20;24[3]:521).":[510],"If":[511],"investigator":[514,553],"holds":[515],"any":[516],"restricted":[517],"relationships,":[518],"his":[519],"her":[521],"abstract":[522],"will":[523],"ineligible":[525],"placement":[527],"2009":[530],"Meeting":[532,640],"unless":[533],"Ethics":[536],"Committee":[537],"grants":[538],"an":[539,547,623],"exception.":[540],"Among":[541],"circumstances":[543],"might":[545],"justify":[546],"exception":[548,624],"are":[549,608,630],"(1)":[554],"widely":[557],"acknowledged":[558],"particular":[562],"therapeutic":[563],"area;":[564],"(2)":[565],"inventor":[568],"unique":[571],"technology":[572],"being":[575],"trial;":[580],"(3)":[582],"involved":[584],"international":[586,596],"oncology":[588],"acted":[592],"consistently":[593],"recognized":[595],"standards":[597],"ethics":[599],"conduct":[602],"research.":[605],"NIH-sponsored":[606],"exempt":[609],"from":[610],"restrictions.":[613],"Abstracts":[614],"requested":[618],"have":[620],"been":[621],"granted":[622],"accordance":[626],"designated":[631],"caret":[634],"symbol":[635],"(^)":[636],"Proceedings.":[641],"information":[644],"about":[645],"exceptions":[654],"process,":[655],"please":[656],"visit":[657],"www.asco.org/conflictofinterest":[658],".":[659]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}